Process for producing recombinant McrBC endonuclease and cleavage of methylated DNA

• US 5,405,760 A
• Filed: 04/30/1992
• Issued: 04/11/1995
• Est. Priority Date: 04/30/1992
• Status: Expired due to Term

• Current Assignee: New England Biolabs Incorporated
• Original Assignee: New England Biolabs Incorporated
• Inventors: Raleigh, Elisabeth A., Hauck, Ellen S.
• Primary Examiner(s): Patterson, Jr., Charles L.
• Application Number:
  US07/876,793
• Time in Patent Office: 1,076 Days
• Field of Search: 435/91, 435/199, 435/320.1, 435/252.33, 536/23.2
• US Class Current: 435/91.53
• CPC Class Codes: C12N 9/22 Ribonucleases RNAses, DNAses catalytic nucleic acids C12N15/113

Abstract

The present invention relates to a recombinant McrBC endonuclease obtainable from Escherichia coli, two components of which, McrB_L and McrC, have been purified in active form. McrBC is active in the presence of GTP and at a low pH. The McrBC endonuclease is also substantially free of a third component, McrB_S, which is believed to inhibit or otherwise interfere with the activity of the enzyme. McrBC has various desirable properties, including the ability to recognize a methylated DNA sequence and also its ability to cleave such a sequence in the presence of GTP. Also provided is a process for the production of recombinant McrBC endonuclease, a process for the determination of the modification state of DNA a process for the determination of an epigenetic alteration or defect (including "imprinting"), as well as a process for identifying and isolating additional enzymes that cleave modified DNA.

Claims

1. A recombinant modified cytosine restriction endonuclease, McrBC, obtainable from Escherichia coli comprising two active components McrB_L and McrC, wherein the endonuclease cleaves a methylated DNA fragment at the Rm5C (N40-100) Rm5C recognition site.

2. The recombinant endonuclease, McrBC, of claim 1, wherein said endonuclease is substantially free of McrB_S.

3. A construct comprising a nucleic acid sequence encoding the McrB_L component of the McrBC endonuclease, wherein said construct substantially does not express McrB_S.

5. A recombinant vector which comprises the construct of claim 3.

7. A host containing the recombinant vector of claim 5.

12. The construct of claim 3, wherein said construct is pER273.

4. A construct which is pER276.

6. A recombinant vector which comprises the construct of claim 4.

8. A host containing the recombinant vector of claim 6.

9. A construct comprising a nucleic acid sequence encoding the McrB_L and McrC component of the McrBC endonuclease, wherein said construct substantially does not express McrB_S.

10. A recombinant vector which comprises the construct of claim 9.

11. A host comprising the recombinant vector of claim 10.

13. A method for producing recombinant McrBC having two active components McrB_L and McrC, comprising isolating a nucleic acid sequence encoding McrB_L and nucleic acid sequence encoding McrC, inserting the isolated DNA into the same or separate vectors to form one or more recombinant vectors, transforming a host cell with the one or more recombinant vectors and culturing the transformed host cells under conditions suitable for expression of the active components of the McrBC nuclease.

14. The method of claim 13 wherein the isolated DNA is inserted into the same vector.

15. The method of claim 13 wherein the isolated DNA is inserted into separate vectors.

16. A method of treating cytosine-modified DNA with recombinant endonuclease, McrBC, which has two active components McrB_L and McrC, comprising determining a recognition sequence of the McrBC endonuclease for a cytosine-modified DNA, mapping locations for McrBC cleavage, and digesting the cytosine-modified DNA substrate with McrBC endonuclease.

17. A method of cleaving cytosine-modified DNA having the sequence Rm5C (N40-100) 5m5c with recombinant endonuclease McrBC which has two active components, McrB_L and McrC, comprising contacting the cytosine-modified DNA with the McrBC endonuclease under suitable conditions.